BPC-157 (5mg / 10mg) Research Peptide: A Stable Gastric Pentadecapeptide for Tissue Repair, Angiogenesis & Musculoskeletal Studies
If your research investigates the molecular mechanisms of tissue repair, angiogenesis, or the modulation of inflammatory pathways across multiple organ systems, BPC-157 (5mg / 10mg) research peptide — also known as Body Protection Compound‑157 — offers a precisely defined and extensively studied synthetic tool. BPC‑157 is a stable gastric pentadecapeptide (15 amino acids) that was first described in the early 1990s as a naturally occurring peptide in human gastric juice with cytoprotective properties.
It is native and stable in human gastric juice for more than 24 hours, and has been the subject of hundreds of preclinical studies exploring its ability to promote healing across multiple tissue types. Preclinical studies show its potential for promoting healing in musculoskeletal injuries such as fractures, tendon ruptures, ligament tears, and muscle injuries. BPC‑157 enhances growth hormone receptor expression and several pathways involved in cell growth and angiogenesis, while reducing inflammatory cytokines. This makes BPC-157 (5mg / 10mg) research peptide a valuable tool for laboratories investigating wound healing, gastrointestinal protection, musculoskeletal repair, angiogenesis, and neuroprotection.
At Chinese Grey Peptides, we supply high‑purity BPC-157 (5mg / 10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into tissue repair, angiogenesis, and cytoprotection begin with uncompromising quality.
What Is BPC‑157 and How Does It Work?
To fully appreciate the research potential of BPC-157 (5mg / 10mg) research peptide, it is essential to understand its biochemical identity, its role as a stable gastric pentadecapeptide, and the mechanisms by which it exerts its pleiotropic effects.
The Stable Gastric Pentadecapeptide
BPC‑157 is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a naturally occurring peptide found in human gastric juice. Its amino acid sequence is Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val (GEPPPGKPADDAGLV). The peptide is notable for its remarkable stability — it is native and stable in human gastric juice for more than 24 hours. This stability is a key feature that distinguishes it from many other research peptides and contributes to its pleiotropic activity across multiple organ systems.
Mechanism of Action: Cytoprotection, Angiogenesis and Organoprotection
The biological activity of BPC-157 (5mg / 10mg) research peptide is mediated through several intersecting mechanisms, rooted in the concept of cytoprotection — the innate ability of cells to protect themselves against injury:
Cytoprotection and Gastrointestinal Protection
BPC‑157 was first described as a cytoprotective agent that protects stomach cells and maintains gastric integrity against various noxious agents. It promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, including healing GI ulcers, anastomotic sites, and various GI fistulas, as well as in models of inflammatory bowel disease. In clinical trials, BPC‑157 has been shown to be safe in inflammatory bowel disease studies, with no side effects reported.
Angiogenesis via VEGFR2 and FAK Signalling
BPC‑157 promotes angiogenesis — the formation of new blood vessels from pre-existing vessels — primarily through the activation of the Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) signalling pathway. It has been concluded to be the most potent angiomodulatory agent, acting through different vasoactive pathways and systems (e.g. NO, VEGF, FAK) and leading to optimisation of the vascular response followed by optimisation of the healing process. BPC‑157 increases angiogenesis and growth hormone receptors, supporting enhanced healing. It resolves cornea transparency maintenance and cornea healing “angiogenic privilege” without producing corneal neovascularisation.
Modulation of the NO‑System and Free Radical Counteraction
BPC‑157 exerts a distinctive effect on nitric oxide (NO) levels — capable of both increasing and decreasing NO as needed — always combined with counteraction of free radical formation. This dual ability to modulate NO while preventing oxidative damage is central to its tissue-protective profile.
Inhibition of Inflammatory Cytokines and Enhancement of Growth Hormone Receptor Expression
BPC‑157 enhances growth hormone receptor expression and reduces inflammatory cytokines. In preclinical models, it has demonstrated improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries.
Organoprotection: Translating Cytoprotection to Other Organs
The cytoprotective effects observed in the gastrointestinal tract can be translated to other tissues through organoprotection. BPC‑157 therapy effectively combines various tissue healing and lesions counteraction across multiple organ systems, including the liver, pancreas, heart, and nerves.
Key Research Applications for BPC-157 (5mg / 10mg)
BPC‑157 (5mg / 10mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.
1. Gastrointestinal & Mucosal Research
As a peptide that promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, BPC‑157 is a valuable tool for studying GI protection and repair. Research applications include:
-
GI Ulcer Healing: Investigating BPC‑157’s ability to heal gastric and intestinal ulcers.
-
Inflammatory Bowel Disease: Studying BPC‑157’s effects in models of IBD, where it has been shown to be safe in clinical trials.
-
NSAID‑Induced Injury: Exploring the peptide’s protective effects against nonsteroidal anti‑inflammatory drug‑induced injury.
-
Anastomotic Healing: Investigating BPC‑157’s potential to promote healing at surgical anastomotic sites.
2. Musculoskeletal & Orthopaedic Research
BPC‑157 has been extensively studied for its effects on musculoskeletal tissues. A systematic review of 36 studies from 1993 to 2024 found that BPC‑157 promotes healing by boosting growth factors and reducing inflammation. Research has demonstrated improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries in preclinical models. Research applications include:
-
Tendon Healing: BPC‑157 accelerates tendon and ligament repair through enhanced fibroblast proliferation and collagen synthesis, primarily via focal adhesion kinase (FAK)-paxillin signalling pathways. It accelerates healing of transected rat Achilles tendon and stimulates tendocyte growth in vitro.
-
Ligament Repair: BPC‑157 promotes healing of the medial collateral ligament in rats after surgical transection.
-
Muscle Injury: BPC‑157 significantly enhances myogenesis, muscle fibre regeneration, and functional recovery post‑injury in skeletal muscle.
-
Bone Fracture Healing: BPC‑157 promotes osteogenesis and accelerates bone healing, particularly under compromised conditions such as delayed union, avascular osteonecrosis, or impaired fracture healing.
3. Angiogenesis & Vascular Research
As a promoter of angiogenesis via VEGFR2 and FAK signalling pathways, BPC‑157 is a valuable tool for studying blood vessel formation and vascular integrity. Research applications include:
-
Angiogenesis Signalling: Investigating the molecular pathways involved in BPC‑157‑induced angiogenesis.
-
Vascular Integrity: Exploring the peptide’s role in supporting vascular integrity and counteracting occlusion disturbances.
-
Corneal Research: BPC‑157 resolves cornea transparency maintenance and cornea healing “angiogenic privilege” without producing corneal neovascularisation.
4. Neuroprotection & Neurotransmitter Research
BPC‑157 has demonstrated neuroprotective effects in preclinical models. Research has shown that BPC‑157 therapy counteracts dopamine, serotonin, glutamate, GABA, adrenalin/noradrenalin, acetylcholine, and NO‑system disturbances. Research applications include:
-
Neurotransmitter Modulation: BPC‑157 counteracts disturbances related to receptors, both blockade and over‑activity, destruction, depletion, tolerance, sensitisation, and channel disturbances.
-
Neurodegenerative Disease Models: Investigating BPC‑157’s potential in CNS disorders.
-
Brain‑Gut Axis: Exploring BPC‑157’s role in brain‑gut and gut‑brain functioning.
5. Pain Modulation Research
Experimental evidence reveals that BPC‑157 supports beneficial effects on pain modulation through peripheral and dopaminergic mechanisms. In a retrospective study of musculoskeletal pain following intraarticular injection of BPC‑157 for unspecified chronic knee pain, 7 of 12 patients reported relief for >6 months.
Chemical & Physical Specifications for BPC-157 (5mg / 10mg)
Accurate characterisation of BPC‑157 (5mg / 10mg) research peptide is essential for reproducible experimental design.
| Parameter | Specification |
|---|---|
| Common Names | BPC‑157, Body Protection Compound‑157, Stable Gastric Pentadecapeptide |
| Amino Acid Sequence (One‑Letter) | GEPPPGKPADDAGLV |
| Amino Acid Sequence (Three‑Letter) | Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val |
| Molecular Weight | ~1499.7 g/mol |
| CAS Number | 137525‑51‑0 |
| Purity | ≥98% (HPLC verified) |
| Appearance | White to off‑white lyophilised powder |
| Solubility | Soluble in sterile water and sterile PBS (pH 5‑7) |
| Stability | Stable in gastric juice for >24 hours |
| Half‑Life | Less than 30 minutes |
| Storage (Lyophilised) | –20°C, sealed, protected from light; stable for up to 2 years |
| Storage (Reconstituted) | 2‑8°C for up to 14‑21 days; single‑use aliquots at –20°C for up to 3 months |
Note: The 5 mg and 10 mg masses refer to the weight of the peptide in its lyophilised form. BPC‑157 is typically supplied as a TFA or acetate salt, which enhances aqueous solubility. BPC‑157 is not FDA‑approved for therapeutic use and is supplied strictly for research use only (RUO).
Reconstitution & Handling Protocol for BPC‑157 (5mg / 10mg)
Proper reconstitution of BPC‑157 (5mg / 10mg) research peptide is critical for maintaining its structural integrity and biological activity. The peptide has a half‑life of less than 30 minutes, so careful handling is essential.
Step 1 – Preparation
-
Bring the sealed BPC‑157 vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.
-
Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.
Step 2 – Vial Sanitisation
-
Wipe the rubber stopper of the BPC‑157 vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.
Step 3 – Reconstitution
-
Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 5 mg or 10 mg per 1 mL of diluent, yielding a 5‑10 mg/mL stock solution.
-
Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.
-
Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.
Step 4 – Aliquoting & Storage
-
Immediately after dissolution, aliquot the reconstituted BPC‑157 into single‑use sterile vials.
-
Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.
-
Once thawed, store at 2‑8°C and use within 14‑21 days.
Concentration Reference Table for BPC-157 (5mg / 10mg)
| Vial Mass | Diluent Volume | Final Concentration |
|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL |
| 5 mg | 1.0 mL | 5 mg/mL |
| 10 mg | 1.0 mL | 10 mg/mL |
| 10 mg | 2.0 mL | 5 mg/mL |
Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.
Storage & Stability Guidelines for BPC-157 (5mg / 10mg)
| Storage Condition | Shelf Life | Notes |
|---|---|---|
| Lyophilised at –20°C, unopened | 2 years | Use desiccant, protect from light |
| Lyophilised at 2‑8°C, unopened | 6‑12 months | –20°C storage is strongly preferred for long‑term stability |
| Reconstituted at 2‑8°C | 14‑21 days | Must be sterile; use aseptic technique for each withdrawal |
| Reconstituted aliquots at –20°C | Up to 3 months | Single freeze only; discard after thawing |
Why Choose Chinese Grey Peptides for BPC-157 (5mg / 10mg)?
As an authentic licensed peptide supplier based in the USA, we supply BPC-157 (5mg / 10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).
-
Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for every batch.
-
GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.
-
Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.
-
Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.
-
USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO). BPC‑157 is not FDA‑approved for therapeutic use and is supplied for research purposes only.
Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.
FAQ: BPC-157 (5mg / 10mg) Research Peptide
What is BPC‑157 research peptide?
BPC‑157 (Body Protection Compound‑157) is a synthetic pentadecapeptide derived from a naturally occurring peptide found in human gastric juice. It is a stable gastric peptide that promotes mucosal integrity, angiogenesis, and tissue healing across multiple organ systems.
What is the sequence and molecular weight of BPC‑157?
The sequence is Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val (GEPPPGKPADDAGLV). Its molecular weight is approximately 1499.7 g/mol.
What are the primary research applications for BPC‑157?
BPC‑157 is used in gastrointestinal and mucosal research (GI ulcer healing, IBD, NSAID‑induced injury), musculoskeletal and orthopaedic research (tendon, ligament, muscle, bone healing), angiogenesis and vascular research, neuroprotection and neurotransmitter research, and pain modulation research.
What is the mechanism of action of BPC‑157?
BPC‑157 acts through multiple mechanisms: it promotes angiogenesis via VEGFR2 and FAK signalling pathways, modulates the NO‑system while counteracting free radicals, reduces inflammatory cytokines, enhances growth hormone receptor expression, and exerts cytoprotective and organoprotective effects.
What purity does your BPC-157 (5mg / 10mg) meet?
Our BPC‑157 is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.
How should I reconstitute BPC‑157?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical starting concentration is 10 mg/mL.
How should I store reconstituted BPC‑157?
Reconstituted BPC‑157 should be stored at 2‑8°C and used within 14‑21 days. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.
Is BPC‑157 stable in solution?
BPC‑157 is notable for its stability — it is native and stable in human gastric juice for more than 24 hours. However, like all peptides, it should be handled with aseptic technique and stored appropriately.
Is BPC‑157 research peptide legal to purchase in the USA?
Yes. BPC‑157 is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: BPC‑157 is not FDA‑approved for therapeutic use and was temporarily banned by WADA in 2022.
Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.
BPC-157 (5mg / 10mg)
- Shop Page
- Bulk Orders Page
- Contact Page
- Shipping & Return Page
- Peptide Purity Page
- PubChem BPC-157
- FDA BPC-157 compounding-risk information
- FDA peptide warning letter example
- Google Product Structured Data
- Rank Math WooCommerce Product Schema
BPC-157 (5mg / 10mg)
Ships to USA, Canada, UK & Europe
Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.
Shipping support may include:
- Order processing updates
- Packaging support
- Tracking information where available
- Wholesale shipment planning
- Destination-based shipping review
- Customer support during transit
Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.
Why Choose Chinese Grey Peptides?
Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.
Customers choose us for:
- Professional peptide supplier support
- Small and wholesale order options
- Product documentation support
- HPLC testing information where available
- Mass Spectrum documentation where available
- International shipping support
- Responsive communication
- Clear order assistance before payment
We aim to make the buying process transparent, professional, and documentation-focused.
BPC-157 (5mg / 10mg)
Important Compliance Notice
BPC-157 5mg / 10mg may be regulated differently depending on the country, product type, labeling, intended use, buyer type, and destination. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, wound-healing claims, tissue-repair claims, gut-health claims, inflammation claims, pain claims, injury-recovery claims, athletic-performance claims, bodybuilding claims, disease claims, treatment claims, or personal-use recommendations.
Customers are responsible for understanding and following all local laws, import rules, prescription requirements, compounding rules, sport-governing rules, and permitted-use requirements before ordering.
From its discovery as a stable gastric pentadecapeptide to its well‑characterised role in promoting angiogenesis, cytoprotection, and tissue healing across multiple organ systems, BPC-157 (5mg / 10mg) research peptide provides a precisely defined and extensively validated platform for advanced biomedical research.
Its ability to activate VEGFR2 and FAK signalling pathways, modulate the NO‑system, reduce inflammatory cytokines, and enhance growth hormone receptor expression — supported by decades of peer‑reviewed research published in PubMed, the International Journal of Molecular Sciences, Pharmaceuticals, and other authoritative journals — makes it a valuable addition to any laboratory investigating gastrointestinal protection, musculoskeletal repair, angiogenesis, or neuroprotection. By choosing high‑purity, lab‑verified BPC-157 (5mg / 10mg) research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.
Ready to advance your research with BPC-157 (5mg / 10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade BPC‑157 delivered directly to your facility in the USA, UK, or Europe.BPC-157 (5mg / 10mg)
BPC-157 (5mg / 10mg)
BPC-157 (5mg / 10mg)
BPC-157 (5mg / 10mg)




Reviews
There are no reviews yet.